20th May 2021 12:44
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION
Name of person dealing (Note 1) | Barclays PLC. |
Company dealt in | WILLIS TOWERS WATSON PLC |
Class of relevant security to which the dealings being disclosed relate (Note 2) | ORD |
Date of dealing | 19 May 2021 |
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
| Class of relevant security: | ORD | ||||
| Long | Short | ||||
| Number | (%) | Number | (%) | ||
(1) | Relevant securities | ||||
1,656,449 | 1.28% | 172,204 | 0.13% | ||
(2) | Derivatives (other than options): | ||||
72,359 | 0.06% | 0 | 0.00% | ||
(3) | Options and agreements to | ||||
| purchase/sell: | 6,100 | 0.00% | 6,100 | 0.00% | |
| TOTAL: | |||||
1,734,908 | 1.35% | 178,304 | 0.14% | ||
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: | Long | Short | ||||
| Number |
| (%) | Number |
| (%) |
(1) Relevant securities |
|
| ||||
(2) Derivatives (other than options) |
|
| ||||
(3) Options and agreements to purchase/sell |
|
| ||||
Total |
|
| ||||
| ||||||
Ap20
3 DEALINGS (Note 4)
(a) Purchases and sales
| Purchase/sale | Number of relevant securities | Price per unit |
| Purchase | 1 | 261.1100 USD |
| Purchase | 1 | 262.1600 USD |
| Purchase | 1 | 261.4200 USD |
| Purchase | 2 | 260.7000 USD |
| Purchase | 2 | 266.8200 USD |
| Purchase | 3 | 260.5600 USD |
| Purchase | 25 | 261.5100 USD |
| Purchase | 43 | 259.8600 USD |
| Purchase | 56 | 259.9110 USD |
| Purchase | 100 | 261.5500 USD |
| Purchase | 100 | 260.5500 USD |
| Purchase | 199 | 260.1901 USD |
| Purchase | 199 | 261.0295 USD |
| Purchase | 200 | 260.5975 USD |
| Purchase | 240 | 259.8952 USD |
| Purchase | 321 | 260.6314 USD |
| Purchase | 363 | 260.5441 USD |
| Purchase | 500 | 260.6870 USD |
| Purchase | 500 | 260.7080 USD |
| Purchase | 600 | 260.7263 USD |
| Purchase | 700 | 260.5757 USD |
| Purchase | 752 | 260.5655 USD |
| Purchase | 772 | 261.0261 USD |
| Purchase | 1,177 | 261.0299 USD |
| Purchase | 2,105 | 260.6728 USD |
| Purchase | 3,458 | 260.6715 USD |
| Purchase | 5,062 | 260.3497 USD |
| Purchase | 5,329 | 260.3180 USD |
| Purchase | 7,972 | 260.5049 USD |
| Purchase | 9,640 | 260.5204 USD |
| Purchase | 17,101 | 261.8600 USD |
| Sale | 8 | 262.0400 USD |
| Sale | 99 | 260.1600 USD |
| Sale | 100 | 261.1800 USD |
| Sale | 125 | 258.7909 USD |
| Sale | 185 | 261.8400 USD |
| Sale | 200 | 260.5975 USD |
| Sale | 200 | 260.0200 USD |
| Sale | 232 | 261.8853 USD |
| Sale | 300 | 259.8433 USD |
| Sale | 502 | 260.5032 USD |
| Sale | 600 | 260.4046 USD |
| Sale | 664 | 260.2019 USD |
| Sale | 1,937 | 260.4289 USD |
| Sale | 2,098 | 260.8821 USD |
| Sale | 2,155 | 260.4426 USD |
| Sale | 5,000 | 260.5738 USD |
| Sale | 7,002 | 260.5229 USD |
| Sale | 7,300 | 260.5308 USD |
| Sale | 10,739 | 260.4919 USD |
| Sale | 16,876 | 261.8600 USD |
(b) Derivatives transactions (other than options transactions)
Product name, e.g. CFD | Nature of transaction (Note 6) | Number of relevant securities (Note 7) | Price per unit (Note 5) |
|
|
|
|
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, e.g. call option | Writing, selling, purchasing, varying etc. | Number of securities to which the option relates (Note 7) | Exercise price | Type, e.g. American, European etc. | Expiry date | Option money paid/received per unit (Note 5) |
|
|
|
|
|
|
|
(ii) Exercising
Product name, e.g. call option | Number of securities | Exercise price per unit (Note 5) |
|
|
|
(d) Other dealings (including transactions in respect of new securities) (Note 4)
Nature of transaction (Note 8) | Details | Price per unit (if applicable) (Note 5) |
|
|
|
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.
None
Is a Supplemental Form 8 attached? (Note 9) NO
Date of disclosure | 20 May 2021 |
Contact name | Large Holdings Regulatory Operations |
Telephone number | 020 3134 7213 |
If a connected EFM, name of offeree/offeror with which connected |
|
If a connected EFM, state nature of connection (Note 10) |
|
View source version on businesswire.com: https://www.businesswire.com/news/home/20210520005584/en/
Copyright Business Wire 2021
Related Shares:
Barclays